Terminated NA INTERVENTIONAL 1-arm NCT04465630

A Prospective, Multicenter Study of the OMNI® Surgical System in Pseudophakic Eyes With Open Angle Glaucoma (ORION)

Sponsor: Sight Sciences, Inc.

Updated 6 times since 2020 Last updated: Jun 6, 2022 Started: Jun 19, 2020 Primary completion: Mar 2, 2021 Completion: Mar 2, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Sponsor Decision

Other terminated trials from Sight Sciences, Inc.

More terminations from Sight Sciences, Inc.

Other Glaucoma, Open-Angle trials with similar outcome

Browse all Glaucoma, Open-Angle trials

A NA clinical study on Glaucoma, Open-Angle, this trial is terminated or withdrawn. The trial is conducted by Sight Sciences, Inc. and has accumulated 6 data snapshots since 2020. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Terminated NA
Jul 2024 — Sep 2024 [monthly]

Terminated NA
Jul 2022 — Jul 2024 [monthly]

Terminated NA

Status: Suspended → Terminated
Mar 2021 — Jul 2022 [monthly]

Suspended NA

Status: Recruiting → Suspended
Jan 2021 — Mar 2021 [monthly]

Recruiting NA

▶ Show 1 earlier version

Aug 2020 — Jan 2021 [monthly]

Recruiting NA

First recorded

Jun 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Sight Sciences, Inc.

Data source: Sight Sciences, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Bloomington, United States , El Paso, United States , Fayetteville, United States , Fort Worth, United States , Maryville, United States , Newport Beach, United States , Ogden, United States , Oklahoma City, United States , Petaluma, United States , Santa Monica, United States and 1 more location